Australians with paroxysmal nocturnal haemoglobinuria (PNH)—a condition that produces defective blood cells—will have access to a new treatment through the Pharmaceutical Benefits Scheme (PBS). PNH is a rare, potentially life-threatening condition in which red blood ...